Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. (Nasdaq: ENSC) is a clinical-stage pharmaceutical company focused on developing abuse-deterrent drug formulations, operating within the healthcare and biotech sector. The company filed an 8-K current report on March 27, 2020, disclosing a material corporate event ahead of its public debut via a SPAC combination with LifeSci Acquisition Corp., sponsored by LifeSci Holdings LLC. The transaction closed in 2021, with the combined entity trading on Nasdaq under the ENSC ticker. For the complete filing record, sponsor profile, deal timeline, and ongoing corporate disclosures for Ensysce Biosciences, sign up for full data access at SpacDesk.